primary

MEDICAL RESEARCH

The Scientists and Doctors Behind our Work

LEADING RESEARCHER

Dominic P.
D’Agostino, PhD

Metabolic Expert

ORIGINAL FORMULATOR

Vincent M.
Tedone, M.D.

Research Physician

LEADING RESEARCHER

Csilla
Ari, PhD

Neuroscientist

LEADING RESEARCHER

Christopher Q.
Rodgers, PhD

Metabolic Expert

LEADING RESEARCHER

Dominic P.
D’Agostino, PhD

Metabolic Expert

LEADING RESEARCHER

Dr. James J. Hickman

LEADING RESEARCHER

Csilla
Ari, PhD

Neuroscientist

ORIGINAL FORMULATOR

Vincent M.
Tedone, M.D.

Research Physician

LEADING RESEARCHER

Christopher Q.
Rodgers, PhD

Metabolic Expert

LEADING RESEARCHER

Dominic P.
D’Agostino, PhD

Metabolic Expert

LEADING RESEARCHER

Dr. James J.
Hickman

Metabolic Expert

LEADING RESEARCHER

Csilla
Ari, PhD

Neuroscientist

ORIGINAL FORMULATOR

Vincent M.
Tedone, M.D.

Research Physician

LEADING RESEARCHER

Christopher Q.
Rodgers, PhD

Metabolic Expert

PRIMARY RESEARCH BY WINNING THE FIGHT

(All URLs contained herein are external links. Should you find a broken link, please help us keep our research current by notifying WFND immediately.)

EVALUATION OF HOLISTIC TREATMENT FOR ALS REVEALS POSSIBLE MECHANISM AND THERAPEUTIC POTENTIAL

Abstract: This article proves that the Deanna Protocol corrects the mal-alignment of the microtubules that connect nerve cells to nerve cells and nerve cells to muscle. The microtubules are the pathways down which signaling occurs between cells. The function of the Tau protein is to maintain this alignment hence the Deanna Protocol restores the function of the Tau protein. Dementia is caused by abnormal signaling between brain nerve cells. Muscle symptoms are caused by abnormal signaling between nerves and muscles. Every neurodegenerative disease has dysfunctional Tau protein hence the Deanna protocol is beneficial in all neurodegenerative diseases such as ALS, AD, MS, PD and others. See link to article listed below.

HUMAN CELL STUDIES FIND DEANNA PROTOCOL EFFECTIVE
(Original Title:  A Human-Based Functional NMJ Study for Personalized ALS Modeling and Drug Testing)

Abstract: This article, which uses the Deanna Protocol, proves that the Deanna Protocol is effective in correcting neuromuscular junction deficits in human ALS cells.

GLUTAMATIC-OXALOACETIC TRANSAMINASE COMBINED WITH METABOLIC THERAPY IN A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS (April 2017)

DEANNA PROTOCOL ON CULTURED HUMAN MOTONEURONS IN VITRO

METABOLIC THERAPY WITH DEANNA PROTOCOL SUPPLEMENTATION DELAYS DISEASE PROGRESSION AND EXTENDS SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) MOUSE MODEL (June 2014)

INCREASED TCA CYCLE INTERMEDIATES IN RESPONSE TO DIET WITH THE DEANNA PROTOCOL IN ALS MOUSE MODEL (June 2014)

EFFECT OF ALTERNATIVE METABOLIC FUELS AS A POTENTIAL ALS THERAPY IN MICE AND HUMANS (July 2013)

DR. TEDONE’S 2013 VIDEO PRESENTATION OF RESEARCH PRIOR TO COMPLETION OF MOUSE STUDIES ABOVE

Dr. Tedone will record an updated video in 2017. (Please note – The Dr. Tedone calls the Deanna Protocol Plan the “Deanna Protocol” or the “DP” for the sake of simplicity, but the legal and official name is the the Deanna Protocol Plan.)

Winning the Fight’s Research in Progress
Winning the Fight is currently conducting a mouse study, at the University of South Florida, that is testing the impact of the combination of the Deanna Protocol Plan and GOT (a substance that will convert glutamate to glutamine to enable the body to expel excess glutamate). GOT was discovered at the Weizmann Institute of Science in Israel.
HAVE QUESTIONS?
CONTACT US!

Read answers to frequently asked questions first.





    Contact Us
    Winning the Fight, Inc.
    11706 North Armenia Avenue
    Tampa, Florida 33612
    ​info@winningthefight.org​